Age (median) | 49 (IQR 3–70) |
Female (%) | 44.5 |
Duration of symptoms before hospitalisation (days) (n=682) | 3 (IQR 1–5) |
Number of listed comorbidities (%) |
0 | 473 (69.4) |
1 | 76 (11.1) |
2 | 72 (10.6) |
3 | 34 (5.0) |
4+ | 27 (4.0) |
Income group (%) |
Low income | 181 (26.5) |
Lower middle income | 121 (17.7) |
Upper middle income | 3 (0.2) |
High income | 377 (55.3) |
Geographical group (%) |
Sub-Saharan Africa | 188 (27.6) |
East Asia and Pacific | 206 (30.2) |
South Asia | 35 (5.1) |
North America | 184 (27.0) |
Europe and Central Asia | 63 (9.2) |
Middle East and North Africa | 3 (0.4) |
Latin America and the Caribbean | 3 (0.4) |
Age group (%) | |
0–10 | 205 (30.0) |
11–20 | 24 (3.5) |
21–30 | 30 (4.4) |
31–40 | 32 (4.6) |
41–50 | 52 (7.6) |
51–60 | 63 (9.2) |
61–70 | 103 (15.1) |
71–80 | 80 (11.7) |
>80 | 83 (12.1) |